Related Experiment Video
Updated: Aug 16, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Influencing Appropriate Statin Use in a Charity Care Primary Clinic
Hasitha Diana Manohar1, Carole Karkour2, Rajesh N Desai2
1Department of Internal Medicine, Loyola University Medical Center, Maywood, IL 60153, USA.
Insights
This study improved statin prescription for diabetes and atherosclerotic cardiovascular disease patients by 25% using a systematic approach. The findings support faster adoption of cholesterol management guidelines.
Area of Science:
- Cardiovascular Medicine
- Clinical Pharmacy
- Health Services Research
Background:
- New 2019 ACC/AHA guidelines show low statin prescription rates (46.4% for DM, 30% for ASCVD).
- Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and disability.
- Systematic interventions to improve statin adherence for ASCVD are understudied.
Purpose of the Study:
- To address the research gap in systematic interventions for statin adherence in ASCVD.
- To investigate the role of pharmacy, providers, E.M.R., and patients in improving cholesterol management with statins.
- To pave the way for future research on cardiovascular and statin regimens.
Main Methods:
- Qualitative observational study conducted in a US northeastern charity care primary clinic.
- Utilized electronic health records (EHR) and electronic prescribing (E-Scribe).
- Implemented four Plan-Do-Study-Act (PDSA) cycles over six months, intensifying interventions with each cycle.
Main Results:
- Achieved a 25% relative improvement in appropriate statin prescription for ASCVD or DM patients within six months.
- Baseline appropriate statin dosing: 77% for cardiovascular disease patients, 80.4% for diabetes patients.
- PDSA cycles demonstrated potential for faster uptake and support of ACC/AHA guidelines.
Conclusions:
- PDSA cycles can significantly improve appropriate statin prescription rates in primary care settings.
- Overcoming barriers like over-prescription and time constraints is crucial for guideline adherence.
- Proactive panel management is key to optimizing statin utilization for cardiovascular risk reduction.
Abstract:
According to the American College of Cardiology/American Heart Association (ACC/AHA) new cholesterol management guidelines in 2019, statin regimen was prescribed to only about 46.4% and 30% of diabetes (DM) patients and patients with atherosclerotic cardiovascular disease (ASCVD), respectively. Atherosclerotic cardiovascular disease accounts for most deaths and disabilities in North America. This study argues that a systematic approach to identifying targeted interventions to adhere to the statin regimen for ASCVD is sparse in previous studies. This study seeks to address the research gap. Besides, the study argues that the statin regimen could improve cholesterol management with the enablers of pharmacy, providers, electronic medical records (E.M.R.), and patients. It paves the way for future research on cardiovascular and statin regimens from different perspectives. Current study has adopted the Qualitative observation method. Accordingly, the study approached the charity care primary clinic serving a large population in the northeastern part of the United States, which constitutes the project's setting. The facility has 51 internal medicine residents. The facility has E.H.R., which is used by the clinical staff. Besides, providers use electronic medication prescribing (E-Scribe). Four PDSA cycles were run in six months. Here, the interventions were intensified during each subsequent cycle. The interventions were then incorporated into routine clinical practice. Based on the observation, the study found a 25% relative improvement by six months based on the baseline data of the appropriate intensity statin prescription for patients with ASCVD or DM by medical resident trainees in our single-center primary care clinic. A total of 77% of cardiovascular disease patients were found to be on an appropriate statin dose at baseline. On the other hand, the proportion of patients with DM who were on proper dose statin was 80.4%. According to the study's findings, PDSA could result in a faster uptake and support of the ACC/AHA guidelines. Evidence indicates that overmedication of persons at low risk and time constraints are some of the most significant impediments to the greater use of prescription medications. Proactive panel management can help improve statins' use by ensuring they are used appropriately.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures

